Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

The global sleep apnea implants market is projected to expand at a compound annual growth rate (CAGR) of approximately 10% ...

A new Australian study has found that a simple saline nasal spray could help many children breathe and sleep better, ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 drug, researchers recently reported in JAMA Network Open. Patients were also ...

Many people think that snoring is just a normal part of sleep. But for some, it can be a sign of a serious and often ignored ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare evolves towards proactive, ...

The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...